BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 324 filers reported holding BIONTECH SE in Q4 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,003,640 | $149,643,000 | 20.73% |
| Bill & Melinda Gates Foundation | 148,674 | $22,200,000 | 17.06% |
| Quinn Opportunity Partners LLC | 300,721 | $44,838,000 | 3.90% |
| PARUS FINANCE (UK) Ltd | 42,953 | $6,404,000 | 3.81% |
| Renaissance Capital LLC | 36,476 | $5,439,000 | 2.90% |
| Baader Bank Aktiengesellschaft | 224,800 | $33,520,000 | 2.58% |
| Tri Locum Partners LP | 39,663 | $5,914,000 | 2.42% |
| MARK ASSET MANAGEMENT LP | 61,734 | $9,205,000 | 2.22% |
| Franchise Capital Ltd | 43,650 | $6,508,000 | 2.18% |
| Boston Common Asset Management, LLC | 283,776 | $42,311,000 | 2.11% |